Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
-0.34%
-0.64%
-1.11%
+18.19%
ABBV
AbbVie
$218.34
Chart
$206.57 (+5.70%)
$185.3 (+17.83%)
$177.05 (+23.32%)
$194.79 (+12.09%)
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.34%
-0.64%
-1.11%
+18.19%
ABBV
AbbVie
Current Price
$218.34
Login to view AbbVie (ABBV) recommendation from the last 90 days from financial news and social media.
Chart
$206.57 (+5.70%)
$185.3 (+17.83%)
$177.05 (+23.32%)
$194.79 (+12.09%)
ABBV has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
ABBV Latest Analysis
AbbVie (ABBV) Shares Cross 3% Yield Mark. Looking at the universe of stocks we cover at Dividend Channel in trading on Friday shares of AbbVie Inc (Symbol: ABBV) were yielding above the 3% mark based on its quarterly dividend (annualized to $6.56) with the stock changing hands as low as $218.24 on the day. Dividends
Today
AbbVie Settles Rinvoq Patent Dispute: What It Means for the Stock. ABBV secures Rinvoqs market lead until 2037 boosting shares as strong sales and new indications fuel long-term growth prospects.
Today
The Best Stocks to Invest $50000 In Right Now. Key PointsAbbVie is a Dividend King thats proven its resilience.
Today
Notable Thursday Option Activity: ABBV LRCX UAL. Looking at options trading activity among components of the S&.P 500 index there is noteworthy activity today in AbbVie Inc (Symbol: ABBV) where a total volume of 26476 contracts has been traded thus far today a contract volume which is representative of approximately 2.6
Thu Sep 11, 2025
Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20 Pharma Companies in the Race | DelveInsight. Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20 Pharma Companies in the Race |. DelveInsightThe bipolar disorder clinical trial landscape is evolving with 25 therapies namely KarXT (BMS) RAP 219 (Rapport Therapeutics) ABBV-932 (AbbVie Inc.) ABX-002 (Autobahn Therapeutics) ALTO-100 (Alto Neuroscience) CB03-154 (Zhimeng Biopharma) 4MT 2001 (4M THERAPEUTICS) and others wh
Thu Sep 11, 2025
Why Is AbbVie Stock Trading Higher On Thursday?. ) stock is trading higher on Thursday following an SEC filing that settled litigation with all which filed abbreviated new drug applications with the United States Food and Drug Administration for generic versions of upadacitinib tablets marketed by the company as Rinvoq.Given the settlement and license agreements which are subject to standard acceleration provisions assuming pediatric exclusivity is granted no generic entry for any upadacitinib
Thu Sep 11, 2025
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It. Recently Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.
Thu Sep 11, 2025
AbbVie stock rises after securing patent protection for RINVOQ until 2037.
Thu Sep 11, 2025
AbbVie Inc. (ABBV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript).
Tue Sep 9, 2025
Glenmark shares gain 2% as firm receives $700 million upfront payment from AbbVie deal . Glenmark Pharmaceuticals shares surged following its subsidiarys $700 million upfront payment from AbbVie for an exclusive licensing agreement concerning IGIs lead drug candidate ISB 2001. The deal grants AbbVie rights in key markets while Glenmark retains commercialization in emerging regions.
Tue Sep 9, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ABBV Stock trends
ABBV Stock performance
ABBV Stock analysis
ABBV investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Hover over the category for more information
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings